Cited by 74Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and TreatmentsLiver Disease and Transplantation

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Symptom development and prognosis in primary biliary cirrhosis: A study in two centers

Open access

Abstract

The prognosis of patients with asymptomatic primary biliary cirrhosis has been uncertain. Cases of primary biliary cirrhosis in 95 patients from two centers are presented: 70 patients from a regional referral center (Freeman Hospital, FH) and 25 from an international tertiary referral center (King's College Hospital, KCH) with similar mean age at diagnosis and duration of follow-up (median, 12 months). During follow-up, 19 of 70 FH patients and 15 of 25 KCH patients developed symptoms (P less than 0.001); the mean time to symptom appearance was 43 months at FH and 35 months at KCH (P = 0.0012). Twenty-five of 95 patients died, 15 of 34 subjects who had developed symptoms (all liver-related deaths) and 10 of 61 who remained asymptomatic (all non-liver-related deaths) (P less than 0.001). Hepatic mortality was worse than among the normal population (P less than 0.05). A comparison of those patients developing symptoms with 111 at FH and 165 at KCH who presented with symptoms suggests no difference in survival once hepatic symptoms appear. In both centers, hepatic mortality was strongly related to symptom appearance in asymptomatic primary biliary cirrhosis: patients developing symptoms resemble those with symptoms at presentation. Other differences between the centers may reflect different referral patterns.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/0016-5085(90)90968-7

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A substantial proportion of asymptomatic PBC patients later develop symptoms, with 36% to 89% becoming symptomatic over average follow-up of 4.5 to 17.8 years.

    “All of these studies provide evidence of progressive disease in a substantial proportion of patients, with between 36% and 89% becoming symptomatic during average follow-up periods ranging from 4.5 to 17.8 years and a median time from diagnosis to the appearance of symptoms between 2 and 4.2 years.”

    From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [46]

    The Abstract reports that 19 of 70 patients at Freeman Hospital and 15 of 25 at King's College Hospital developed symptoms—34 of 95 patients, or about 36%. The Results give a median follow-up of 69 months for initially asymptomatic patients. This study supports the lower symptom-development figure, but does not itself report 89% or average follow-up spanning 4.5 to 17.8 years; those figures in the citing sentence refer to the studies collectively. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Mitchison, H. C., Lucey, M. R., Kelly, P. J., Neuberger, J. M., Williams, R., & James, O. F. W.
Affiliations
University of Michigan (US)
Venue
Gastroenterology
Publisher
Elsevier BV
Published
1990-09
Volume
99
Issue
3
Pages
778-784
ISSN
0016-5085 (ISSN-L)
OpenAlex
W1799876023
Cited by
74
References
16
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2021: 1 · 2020: 2 · 2018: 4 · 2017: 2 · 2014: 2
FWCI
1.90
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
primary biliary cirrhosis, asymptomatic disease, symptom development, prognosis, survival, time to symptom onset, referral patterns, liver-related mortality
MeSH terms
Adult, Aged, Female, Follow-Up Studies, Humans, Liver Cirrhosis, Biliary, Liver Function Tests, Male, Middle Aged, Prognosis, Retrospective Studies, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review